These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 294932)

  • 21. Metabolic aspects of nephrolithiasis.
    J Tenn Med Assoc; 1986 Nov; 79(11):699-705. PubMed ID: 3795931
    [No Abstract]   [Full Text] [Related]  

  • 22. [Whewellite and weddellite: toward a different etiopathogenesis. The significance of morphological typing of calculi].
    Daudon M; Réveillaud RJ
    Nephrologie; 1984; 5(5):195-201. PubMed ID: 6531056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Urate nephrolithiasis. Cause of consequence?].
    Mertz DP
    Fortschr Med; 1976 Jul; 94(20-21):1160-4. PubMed ID: 955552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formation of renal stones may be prevented by restoring normal urinary composition.
    Pak CY
    Proc Eur Dial Transplant Assoc; 1983; 20():371-85. PubMed ID: 6361751
    [No Abstract]   [Full Text] [Related]  

  • 25. Renal calculi: pathogenesis, diagnosis, and medical therapy.
    Preminger GM
    Semin Nephrol; 1992 Mar; 12(2):200-16. PubMed ID: 1561497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical therapy of renal calculi.
    Drach GW; Smith MJ; Boyce WH
    J Urol; 1970 Nov; 104(5):635-9. PubMed ID: 5486841
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of renal calculi.
    Coe FL; Favus MJ
    Adv Intern Med; 1980; 26():373-92. PubMed ID: 7013442
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease.
    Baggio B; Gambaro G; Favaro S; Borsatti A
    Nephron; 1983; 35(1):11-4. PubMed ID: 6888620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of supersaturation levels and crystallization rates of calcium oxalate from urines of normal humans and stone formers: effects of nondialyzable materials.
    Gill WB; Roma MJ
    J Surg Res; 1976 Jul; 21(1):45-9. PubMed ID: 933515
    [No Abstract]   [Full Text] [Related]  

  • 30. [Resorption of oxalic acid in calcium oxalate nephrolithiasis].
    Müller G; Schütte W; Berg W; Möller T
    Z Urol Nephrol; 1987 Jul; 80(7):391-4. PubMed ID: 3660960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemical analysis of post-lithotripsy stone fragments: a critical evaluation.
    Das G; Hallson PC; Kasidas GP; Samuell CT; Virdi JS; Wickham JE
    Br J Urol; 1993 Oct; 72(4):498-502. PubMed ID: 8261308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nephrolithiasis in childhood inflammatory bowel disease.
    Clark JH; Fitzgerald JF; Bergstein JM
    J Pediatr Gastroenterol Nutr; 1985 Oct; 4(5):829-34. PubMed ID: 2995632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of inhibitor and nucleator activities in calcium stone formers.
    Duranti E; Imperiali P; Badii M; Capiccioni S; Masi MG; Sasdelli M
    Proc Eur Dial Transplant Assoc; 1983; 20():445-9. PubMed ID: 6657667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kidney stones.
    Bushinsky DA
    Adv Intern Med; 2001; 47():219-38. PubMed ID: 11795076
    [No Abstract]   [Full Text] [Related]  

  • 35. Medical treatment of urolithiasis.
    Wilson DM
    Geriatrics; 1979 Aug; 34(8):65-9, 72. PubMed ID: 447088
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dietary food fiber supplements in the treatment of absorptive calciuria].
    Tizzani A; Casetta G; Vercelli D; Piana P
    Minerva Urol Nefrol; 1987; 39(3):225-33. PubMed ID: 2830679
    [No Abstract]   [Full Text] [Related]  

  • 37. Metabolic basis of renal-stone disease.
    Broadus AE; Thier SO
    N Engl J Med; 1979 Apr; 300(15):839-45. PubMed ID: 34098
    [No Abstract]   [Full Text] [Related]  

  • 38. Uric acid/calcium oxalate nephrolithiasis. Clinical and biochemical findings in 86 patients.
    Rapado A; Castrillo JM; Diaz-Curiel M; Traba ML; Santos M; Cifuentes-Delatte L
    Adv Exp Med Biol; 1980; 122A():109-13. PubMed ID: 7424622
    [No Abstract]   [Full Text] [Related]  

  • 39. Inorganic phosphate treatment of nephrolithiasis.
    Ettinger B; Kolb FO
    Am J Med; 1973 Jul; 55(1):32-7. PubMed ID: 4715930
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of oxalate and calcium oxalate activity and formation product ratio in patients with renal stones before and during treatment.
    Peña JC; Monforte MF; Briceño A
    J Urol; 1987 Nov; 138(5):1137-40. PubMed ID: 3669156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.